- Home
- LFVN vs MIRA Comparison
LFVN vs MIRA Comparison
Compare LFVN & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFVN | MIRA |
|---|---|---|
| Founded | N/A | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.0M | 53.2M |
| IPO Year | 1996 | 2023 |
Fundamental Metrics
Financial Performance| Metric | LFVN | MIRA |
|---|---|---|
| Price | $5.18 | $1.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 165.1K | 124.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.69% | N/A |
| EPS Growth | ★ 226.09 | 20.31 |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $203,204,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $25.68 | ★ N/A |
| Revenue Growth | ★ 1.86 | N/A |
| 52 Week Low | $3.90 | $0.81 |
| 52 Week High | $17.64 | $2.45 |
Technical Indicators
Market Signals| Indicator | LFVN | MIRA |
|---|---|---|
| Relative Strength Index (RSI) | 52.51 | 44.59 |
| Support Level | $4.32 | $1.13 |
| Resistance Level | $5.32 | $1.35 |
| Average True Range (ATR) | 0.31 | 0.08 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 83.17 | 46.54 |
Price Performance
Historical ComparisonAbout LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.